The reason of failures.

I have been working  at a pharmaceutical company as MedChem for over 10 years. The progress of science is remarkable, there are lots of technologies in these area. But Drug Discovery project is still challenging area I think.

An article In nature reviews drug discovery analyzed the reason of failures in Phase II and III. It was informative for me.

http://www.nature.com/nrd/journal/v15/n12/full/nrd.2016.184.html

The author analyzed the reason of failures for the period 2013-2015. Fig 1 shows reason for clinical trial failures 2013-2015. The primary reason of failure in Phase II and III is “Efficacy” ! I think it shows difficulty of translational research. It is hard to translate rodent to human. Second reason is safety in PhaseII and PhaseIII. The proportion of safety reason  decreased in the period 2013-2015 compared with the period 2008-2010 in PhaseIII.

Medicinal Chemistry is challenging work.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s